Dr. Joshua John-Ram SchacterDr. Joshua Schacter, DO FAAOS, is America’s Holistic Orthopedic Surgeon, with nearly two decades of surgical expertise.

Orthobiologics: Safer Option for Joint Pain

7 Oct 2025 · 1 min

Watch on YouTube

0:53

YouTube video (talk/transcript) by Dr. Joshua John-Ram Schacter introducing orthobiologics as a growing, research-founded field in orthopedics. The speaker describes orthobiologics as part of his practice for over 10 years, notes the field has existed for 25+ years, and cites market growth from about $5.9 billion currently to $8–10 billion by 2028. He frames orthobiologics as a means to prevent or delay surgery and as operating largely outside traditional insurance models.

Questions this video answers

10+ years

25+ years

From $5.9 billion per year (current) to $8–10 billion by 2028

Chapters

Is certainly something that people are interested in, and this lies outside. Typically, what would be considered a traditional insurance model for treatment.
You know, orthobiologics has been a very integrative part of my practice for 10 plus years. Orthobiologics is an industry, has been growing. It's very well founded in research. It's been around for 25 plus years. And in orthopedics, we've used it to augment repairs and to make our work better for years. But orthobiologics by itself is an industry that really help patients prevent surgery or put off surgery for a long time. The orthobiologics and integrative care system is growing. It's expected to grow from $5.9 billion per year this year to 8 to 10 billion in 2028. So Orthobiologics is certainly something that people are interested in. And this lies outside. Typically, what would be considered a traditional insurance model for treatment.